The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today announced several important decisions to ...

Umeme now says that it will escalate a $292m (Shs1.06 trillion) claim against government in an arbitration process in London, a figure that is slightly higher than the $234m (Shs850.19b) it had ...

There were 146 Shareholders represented virtually or by proxy at the Meeting holding an aggregate of 210,726,733 common shares, representing 50.76% of MediPharm’s total issued and outstanding common ...